CLASS IIIDrug recall · Reported 7 Feb 2018 · FDA Enforcement Report
Indian God Lotion Spray, labeling is in foreign language recalled
A&H Focal is recalling Indian God Lotion Spray, labeling is in foreign language, distributed in New Jersey, New York. The recall was initiated on 7 Mar 2017 and the FDA has classified it as Class III.
Check your package
Lot, batch or date codesAll Lots
Quantity recalledunknown
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Marked Without An Approved NDA/ANDA: FDA analysis found this product to contain diethyl phthalate, an inactive ingredient in several modified release solid oral dosage forms, making this product unapproved drug for which safety and efficacy have not been establish and therefore, subject to recall.
Products marketed as supplements sometimes contain undeclared prescription drug ingredients such as sildenafil or sibutramine. These can interact dangerously with other medicines.
Product as listed by the FDA
Indian God Lotion Spray Bottle, labeling is in foreign language
Where it was distributed
NY and NJ through six retail stores named "Asian Food Markets"
Marked Without An Approved NDA/ANDA: FDA analysis found this product to contain diethyl phthalate, an inactive ingredient in several modified release solid oral dosage forms, making this product unapproved drug for which safety and efficacy have not been establish and therefore, subject to recall.
Which lots are affected?
All Lots
Where was it sold?
NY and NJ through six retail stores named "Asian Food Markets"
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.